Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nerea Torres Added: 5 months ago
Dr Nerea Torres (Our Lady of Candelaria University Hospital, ES) highlights how enhanced ICM remote data management helps clinicians handle cardiac data more efficiently, featuring Assert-IQ by Abbott. Learn how this new insertable cardiac monitor delivers clear, actionable insights and seamless remote connectivity to support effective monitoring of patients with arrhythmias – ensuring the right… View more
Author(s): Nishaki Mehta, Stavros Mountantonakis, Atul Verma ,et al Start date: Feb 05, 2025
This one-hour session provides a concise and practical overview of hemolysis including its pathophysiology, detection and clinical consequences. Gain actionable insights into hemolysis and PFA technologies through a review of preclinical data as well as real-world strategies for patient selection and procedural optimization.Moderated by Dr Nishaki Mehta (Corewell William Beaumont University… View more
Author(s): Arian Sultan , Daniel Scherr Added: 8 months ago
In this three-part peer-to-peer discussion, Dr Arian Sultan (Asklepios Clinic Hamburg, Hamburg, DE) and Prof Daniel Scherr (Medical University of Graz, Graz, AT) review the SmartfIRE study, presenting 12-month safety and efficacy data for the THERMOCOOL SMARTTOUCH™ SF Dual Energy Platform in paroxysmal AF.The series opens with an overview of the study design, recommended workflow and key results… View more
Author(s): Lucas Boersma Added: 9 months ago
ESC Congress 2025 - FARADISE Registry finds FARAPULSE™ pulsed field ablation (PFA) system safe and easy to use, with an 80% clinical effectiveness at one year in paroxysmal AF.Prof Lucas Boersma (St Antonius Hospital, Nieuwegein, NL) joins us to discuss one-year findings from the observational, prospective, single-arm FARADISE global registry (NCT05501873) which collected real-world data from up… View more
Author(s): Jack McCready , Richard Balasubramaniam , Added: 7 months ago
Real-world perspectives from PulseSelect™ and Affera™With lots of new pulsed-field ablation (PFA) technology becoming available, one key question emerges: How are these systems performing in real-world clinical practice? This on-demand version of the session takes you inside the lab to share practical perspectives from physicians at the forefront of PFA adoption.Chaired by Dr Jack McCready… View more
Author(s): Jack McCready, Richard Balasubramaniam, Sandeep Panikker Start date: Nov 07, 2025
Real-world perspectives from PulseSelect™ and Affera™With lots of new pulsed-field ablation (PFA) technology becoming available, the most important question becomes: How are they performing in the real-world? This session will dive into the lab to share practical perspectives from physicians at the forefront of adoption. Join Dr Jack McCready(University Hospitals Sussex NHS Foundation Trust, UK)… View more
Author(s): Domenico G Della Rocca , Gian-Battista Chierchia Added: 1 year ago
Prof. Chierchia & Dr. Della Rocca share their perspectives on the PERFECT-PAF trial, which evaluates the clinical safety and economic value of FARAPULSETM PFA compared to cryoablation (CBA). In the interview, they highlight the study's design and key findings, along with its impact on clinical practice. View more
Author(s): Pugazhendhi Vijayaraman , Marek Jastrzębski , Óscar Cano Added: 1 year ago
Conduction System Pacing: Recent Advances and Clinical ApplicationsConduction system pacing (CSP) has significantly evolved in recent years, expanding from His bundle pacing to include left bundle branch pacing and left ventricular septal pacing. This webinar, led by Dr Pugazhendhi Vijayaraman, a renowned expert in the field, features presentations from esteemed faculty, Prof Marek Jastrzębski… View more
Author(s): Vivek Reddy Added: 2 years ago
EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.Interview… View more